LOC728200 Inhibitors
LOC728200 kinase inhibitors such as Staurosporine, PD98059, LY294002, and U0126 can alter the phosphorylation state of proteins within signaling cascades that may modulate the activity or localization of LOC728200. Similarly, inhibitors that affect gene expression, like 5-Azacytidine and Sodium butyrate, can lead to changes in the transcription levels of LOC728200, thereby influencing its cellular concentration. Compounds like MG132 and Cycloheximide act on the protein turnover processes, with MG132 preventing proteasomal degradation and Cycloheximide inhibiting protein synthesis, which can result in altered levels of LOC728200.
Additionally, Gefitinib, through its inhibition of EGFR, can impact various downstream signaling pathways, potentially affecting those that LOC728200 is part of. Metformin and 2-Deoxy-D-glucose, by modulating cellular metabolism and energy pathways, can influence the function and regulation of proteins sensitive to changes in cellular energy states, which may include LOC728200.Collectively, these inhibitors encompass a broad spectrum of chemical activities, from targeting kinases to altering metabolic states, each with the capacity to indirectly impact the biological context in which LOC728200 operates.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor that can disrupt kinase-dependent signaling pathways, potentially affecting the phosphorylation state and activity of LOC728200. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
An inhibitor of DNA methyltransferases that can alter gene expression, potentially affecting LOC728200 expression levels. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that can prevent the degradation of protein, potentially stabilizing LOC728200 and increasing its cellular concentration. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
An inhibitor of eukaryotic protein synthesis that can decrease overall protein levels, potentially reducing the synthesis of LOC728200. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A MEK inhibitor that can affect the MAPK/ERK pathway, potentially altering the activity and regulation of LOC728200. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that can affect AKT signaling, potentially influencing the activity and regulation of LOC728200. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can affect protein synthesis and other processes, potentially reducing the expression of LOC728200. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
A histone deacetylase inhibitor that can change chromatin structure and gene expression, potentially affecting the expression of LOC728200. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
An EGFR inhibitor that can affect downstream signaling pathways, potentially impacting the regulatory processes involving LOC728200. | ||||||
1,1-Dimethylbiguanide, Hydrochloride | 1115-70-4 | sc-202000F sc-202000A sc-202000B sc-202000C sc-202000D sc-202000E sc-202000 | 10 mg 5 g 10 g 50 g 100 g 250 g 1 g | $20.00 $43.00 $63.00 $156.00 $260.00 $510.00 $31.00 | 37 | |
An AMPK activator that can influence cellular metabolism and energy status, potentially affecting the activity and regulation of LOC728200. | ||||||